- Home
- GLBS vs EVAX Comparison
GLBS vs EVAX Comparison
Compare GLBS & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLBS
- EVAX
- Stock Information
- Founded
- GLBS 2006
- EVAX 2008
- Country
- GLBS Greece
- EVAX Denmark
- Employees
- GLBS N/A
- EVAX N/A
- Industry
- GLBS Marine Transportation
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GLBS Consumer Discretionary
- EVAX Health Care
- Exchange
- GLBS Nasdaq
- EVAX Nasdaq
- Market Cap
- GLBS 21.9M
- EVAX 17.8M
- IPO Year
- GLBS 2007
- EVAX 2021
- Fundamental
- Price
- GLBS $1.05
- EVAX $2.93
- Analyst Decision
- GLBS Strong Buy
- EVAX Strong Buy
- Analyst Count
- GLBS 1
- EVAX 2
- Target Price
- GLBS $3.00
- EVAX $10.00
- AVG Volume (30 Days)
- GLBS 27.3K
- EVAX 68.5K
- Earning Date
- GLBS 09-12-2025
- EVAX 10-30-2025
- Dividend Yield
- GLBS N/A
- EVAX N/A
- EPS Growth
- GLBS N/A
- EVAX N/A
- EPS
- GLBS N/A
- EVAX N/A
- Revenue
- GLBS $35,776,000.00
- EVAX $3,176,000.00
- Revenue This Year
- GLBS $5.01
- EVAX N/A
- Revenue Next Year
- GLBS $27.86
- EVAX $425.50
- P/E Ratio
- GLBS N/A
- EVAX N/A
- Revenue Growth
- GLBS 17.92
- EVAX 1042.45
- 52 Week Low
- GLBS $0.99
- EVAX $1.20
- 52 Week High
- GLBS $2.21
- EVAX $16.69
- Technical
- Relative Strength Index (RSI)
- GLBS 50.05
- EVAX 51.89
- Support Level
- GLBS $1.01
- EVAX $2.81
- Resistance Level
- GLBS $1.09
- EVAX $3.04
- Average True Range (ATR)
- GLBS 0.04
- EVAX 0.21
- MACD
- GLBS 0.01
- EVAX -0.00
- Stochastic Oscillator
- GLBS 55.56
- EVAX 68.64
About GLBS Globus Maritime Limited
Globus Maritime Ltd is a dry bulk shipping company that provides marine transportation services internationally. The company owns, operates, and manages a fleet of dry bulk vessels that transport iron ore, coal, grain, steel products, cement, alumina, and other dry bulk cargo. Its operations are managed by its subsidiary which also provides in-house commercial and technical management for its vessels and also offers consulting services for an affiliated ship management company. It generates maximum revenues by charging customers for the use of vessels to transport dry bulk commodities.
About EVAX Evaxion Biotech
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.